We provide patient-derived xenograft (PDX) models used to evaluate safety and efficacy. we have:
Pancreatic Ductal Adenocarcinoma (PDAC) Pancreatic Cancer PDX Collection – in vivo screening for drug efficacy, tumor kinetics and animal survival studies

Gastrointestinal (GI) PDX Collection (Esophageal, Gastric, Colorectal and liver cancer models) – histological analysis and SOC studies

Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung cancer (SCLC) and Mesothelioma PDX Collection – WES – mutational and RNA-seq gene expression analysis for model selection

Lymphoma PDX Collection – SOC studies, subcutaneous (SQ) and disseminating implantation studies

Bladder Cancer PDX Collection – application of PDX models for immune-oncology

Radiation Therapy Core –RT/drug combination studies with combinations of chemotherapies, targeted agents, and immune-oncology drugs with whole body and focal radiation therapy